Agalsidase alfa (Replagal(™)) in the treatment of Anderson-Fabry disease

Por Pastores, Gregory M
Publicado em 2007

Therapeutic approaches for lysosomal storage diseases

Por Pastores, Gregory M.
Publicado em 2010

A systematic review of new advances in the management of mucopolysaccharidosis VI (Maroteaux-Lamy syndrome): focus on galsulfase

Por El Dib, Regina P, Pastores, Gregory M
Publicado em 2009

Dosing Enzyme Replacement Therapy for Gaucher disease: Older, but are we wiser?

Por Sidransky, Ellen, Pastores, Gregory M., Mori, Motomi
Publicado em 2009

Neuropathic Lysosomal Storage Disorders

Por Pastores, Gregory M., Maegawa, Gustavo H.B.
Publicado em 2013

Focal splenic lesions in type I Gaucher disease are associated with poor platelet and splenic response to macrophage-targeted enzyme replacement therapy

Por Stein, Philip, Malhotra, Advitya, Haims, Andrew, Pastores, Gregory M., Mistry, Pramod K.
Publicado em 2010

Evaluation of high density lipoprotein as a circulating biomarker of Gaucher disease activity

Por Stein, Philip, Yang, Ruhua, Liu, Jun, Pastores, Gregory M., Mistry, Pramod K.
Publicado em 2011

Non–pseudogene-derived complex acid β-glucosidase mutations causing mild type 1 and severe type 2 Gaucher disease

Por Grace, Marie E., Ashton-Prolla, Patricia, Pastores, Gregory M., Soni, Agnes, Desnick, Robert J.
Publicado em 1999

Expanding spectrum of the association between type 1 Gaucher disease and cancers: a series of patients with up to 3 sequential cancers of multiple types – correlation with genotype...

Por Lo, Sarah M., Stein, Philip, Mullaly, Sean, Bar, Michael, Jain, Dhanpat, Pastores, Gregory M., Mistry, Pramod K.
Publicado em 2010

A multicenter open-label treatment protocol (HGT-GCB-058) of velaglucerase alfa enzyme replacement therapy in patients with Gaucher disease type 1: safety and tolerability

Por Pastores, Gregory M., Rosenbloom, Barry, Weinreb, Neal, Goker-Alpan, Ozlem, Grabowski, Gregory, Cohn, Gabriel M., Zahrieh, David
Publicado em 2014

Agalsidase alfa in pediatric patients with Fabry disease: a 6.5-year open-label follow-up study

Por Schiffmann, Raphael, Pastores, Gregory M, Lien, Yeong-Hau H, Castaneda, Victoria, Chang, Peter, Martin, Rick, Wijatyk, Anna
Publicado no Orphanet J Rare Dis (2014)

Life expectancy in Gaucher disease type 1

Por Weinreb, Neal J., Deegan, Patrick, Kacena, Katherine A., Mistry, Pramod, Pastores, Gregory M., Velentgas, Priscilla, vom Dahl, Stephan
Publicado em 2008

Type II NKT-T(FH) cells against Gaucher lipids regulate B-cell immunity and inflammation

Por Nair, Shiny, Boddupalli, Chandra Sekhar, Verma, Rakesh, Liu, Jun, Yang, Ruhua, Pastores, Gregory M., Mistry, Pramod K., Dhodapkar, Madhav V.
Publicado no Blood (2015)

Joint contractures in the absence of inflammation may indicate mucopolysaccharidosis

Por Cimaz, Rolando, Coppa, Giovanni Valentino, Koné-Paut, Isabelle, Link, Bianca, Pastores, Gregory M, Elorduy, Maria Rua, Spencer, Charles, Thorne, Carter, Wulffraat, Nico, Manger, Bernhard
Publicado em 2009

Enzyme replacement therapy with taliglucerase alfa: 36‐month safety and efficacy results in adult patients with Gaucher disease previously treated with imiglucerase

Por Pastores, Gregory M., Shankar, Suma P., Petakov, Milan, Giraldo, Pilar, Rosenbaum, Hanna, Amato, Dominick J., Szer, Jeffrey, Chertkoff, Raul, Brill‐Almon, Einat, Zimran, Ari
Publicado no Am J Hematol (2016)

The underrecognized progressive nature of N370S Gaucher disease and assessment of cancer risk in 403 patients

Por Taddei, Tamar H., Kacena, Katherine A., Yang, Mei, Yang, Ruhua, Malhotra, Advitya, Boxer, Michael, Aleck, Kirk A., Rennert, Gadi, Pastores, Gregory M., Mistry, Pramod K.
Publicado em 2009

Clinical course and prognosis in patients with Gaucher disease and parkinsonism

Por Lopez, Grisel, Kim, Jenny, Wiggs, Edythe, Cintron, Dahima, Groden, Catherine, Tayebi, Nahid, Mistry, Pramod K., Pastores, Gregory M., Zimran, Ari, Goker-Alpan, Ozlem, Sidransky, Ellen
Publicado no Neurol Genet (2016)

Glucosylsphingosine is a key Biomarker of Gaucher Disease

Por Murugesan, Vagishwari, Chuang, Wei-Lien, Liu, Jun, Lischuk, Andrew, Kacena, Katherine, Lin, Haiqun, Pastores, Gregory M, Yang, Ruhua, Keutzer, Joan, Zhang, Kate, Mistry, Pramod K
Publicado no Am J Hematol (2016)

Juvenile-onset motor neuron disease caused by novel mutations in β-hexosaminidase

Por Pierson, Tyler Mark, Torres, Paola A., Zeng, Bei-Jin, Glanzman, Allan M., Adams, David, Finkel, Richard S., Mahuran, Don J., Pastores, Gregory M., Tennekoon, Gihan I., Kolodny, Edwin H.
Publicado em 2012

Genome-wide Association Study of N370S Homozygous Gaucher Disease Reveals the Candidacy of CLN8 gene as a Genetic Modifier Contributing to Extreme Phenotypic Variation

Por Zhang, Clarence K., Stein, Philip B., Liu, Jun, Pastores, Gregory M., Wang, Zuoheng, Yang, Ruhua, Cho, Judy H., Gregersen, Peter K., Aerts, Johannes M. F. G., Zhao, Hongyu, Mistry, Pramod K.
Publicado em 2012